MOODY’S-ESG-SOLUTIONS
26.4.2022 11:19:04 CEST | Business Wire | Press release
Moody’s today launched Moody’s ESG360™, an easy-to-use platform that provides portfolio managers with ESG analyst-verified scores and modelled ESG and climate intelligence on private and public companies to bring clarity and confidence to investment decisions on environmental, social and governance (ESG) issues.
“To understand the short- and long-term impact of ESG and climate exposures, market participants need a holistic and reliable view of risks and opportunities,” said Andrea Blackman, Managing Director – Global Head of Moody’s ESG Solutions. “The launch of Moody’s ESG360™ demonstrates our commitment to providing comprehensive coverage to help portfolio managers make sustainable decisions with confidence. Coverage is much more than just a number; it’s a commitment to providing granular and clearly defined data, scores, and assessments – all delivered through platforms that meet customer needs.”
Moody’s ESG360™ allows portfolio managers to identify ESG leaders and laggards across themes, sectors, and regions, monitor and report on portfolio level performance across a broad range of research lines, and analyze key risk metrics at both the portfolio and entity level. All data points will be clearly labeled with their relevance to industry standards and traceable to their source.
At launch, Moody’s ESG360™ provides access to Moody’s physical and transition climate risk data sets across a recently expanded universe of 10,000 companies globally. In the coming months, the platform will be further enhanced with Moody’s ESG insights, including coverage of 300 million public and private companies through a combination of modelled and ESG analyst-verified scores.
Driven by a double materiality approach that accounts for both financial and stakeholder impacts, Moody’s ESG data, scores, and assessments provide a comprehensive view of the ESG performance of companies – including small and medium-sized enterprises (SMEs). This enables a unique assessment of how companies can create sustainable value for the environment, society, and stakeholders, as well as how companies are positioned to manage their exposure and response to ESG risks and opportunities.
Alongside Moody’s ESG360™, Moody’s recently launched a corporate engagement platform, Moody’s ESG360™ Connect, which enables corporates to easily connect with Moody’s regarding their sustainability disclosures and ensure accurate representation of their ESG data, ultimately expanding the data coverage that feeds into Moody’s ESG solutions.
To learn more about Moody’s ESG360™ or get a demo, visit: http://www.moodys.com/moodys-esg360 .
Sustainability is at the core of Moody's business, building better business, better lives and better solutions to create long-term value for society, the environment and the economy. For more information on Moody’s sustainability commitments, visit: https://about.moodys.io/sustainability
ABOUT MOODY’S ESG SOLUTIONS
Moody’s ESG Solutions is a business unit of Moody’s Corporation serving the growing global demand for ESG and climate insights. The group leverages data and expertise across ESG, climate risk, and sustainable finance, and aligns with Moody's Investors Service and Moody's Analytics to deliver a comprehensive, integrated suite of ESG and climate risk solutions including ESG scores, analytics, Sustainability Ratings and Sustainable Finance Reviewer/certifier services.
For more information visit, Moody’s ESG hub at www.moodys.com/esg .
View source version on businesswire.com: https://www.businesswire.com/news/home/20220426005612/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces Positive CHMP Opinion for Zynyz® (retifanlimab) for First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)30.1.2026 15:29:00 CET | Press release
Pending the European Commission decision, Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) will be the first PD-1 immunotherapy treatment for patients with advanced squamous cell carcinoma of the anal canal (SCAC) in EuropeGlobally, the prevalence of SCAC is estimated at around 1 or 2 cases per 100,000 people, with a higher incidence in women than in men1,2,3The Committee for Medicinal Products for Human Use (CHMP) positive opinion is based on data from the Phase 3 POD1UM-303/InterAACT2 trial which showed patients with advanced SCAC achieved significantly improved progression-free survival with Zynyz in combination with carboplatin and paclitaxel as a first-line treatment4 Incyte (Nasdaq:INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (
Mediawan to Acquire The North Road Company, Creating a New Global Independent Content Platform30.1.2026 13:32:00 CET | Press release
Mediawan, the leading independent European studio led by Pierre-Antoine Capton, co-founded by Capton, Xavier Niel and Matthieu Pigasse, today announced the signing of an agreement to acquire The North Road Company (“North Road”), the preeminent independent U.S.-based studio founded by Peter Chernin. The combination creates one of the world’s largest independent studios with major creative hubs in the five continents and capabilities spanning all genres, formats and audiences. Together, Mediawan and North Road will have a stronger ability to accelerate the development of powerful IP, foster fresh creative synergies through format adaptations and co-production opportunities, and deliver ever greater value to viewers, talent and partners worldwide. The acquisition brings together two of the most dynamic independent studios in the sector with world-class creative talent, premium IP, and the scale to deliver content at the highest level. In an industry undergoing significant consolidation,
BrightSign Powers Intelligent Signage Experiences at ISE 202630.1.2026 09:00:00 CET | Press release
The Latest Players and AI Capabilities Drive Captivating, Personalized, and Interactive Signage With more industries embracing the power of visual storytelling, BrightSign, the provider of the most advanced, capable, and trusted digital media players and operating system, will showcase the latest developments in digital signage technology at ISE 2026 in Barcelona, Spain from February 3-6, 2026. BrightSign’s latest innovations come to life at booth #4S-150 through interactive real-world demos featuring retail, QSR, transportation, and corporate use cases. Visitors can test new AI-powered object detection capabilities of BrightSign players, allowing them to pick up an object and see the content on the screen respond immediately. Booth activations will be powered by BrightSign’s reliable platform including bsn.Control, BrightSignOS™, brightAuthor connected, and its global partner ecosystem. “In today’s immersive, personalized and visual world, the stakes have never been higher for powerfu
Candela Ushers in a New Era of Aesthetic Innovation at IMCAS Paris With the Launch of the Glacē™ System30.1.2026 08:30:00 CET | Press release
Iconic Vbeam® Pro and Matrix™ Systems showcased ahead of broader commercial availability Candela, a global leader in energy-based aesthetic technologies, today announced the European launch of the Glacē™ System, a facial treatment platform that signals a bold new chapter for the company and the future of aesthetic medicine. In addition to the launch of the Glacē System, Candela will also showcase its Matrix system for radiofrequency-based skin renewal and its iconic Vbeam® Pro vascular treatment platform at IMCAS 2026. Both Matrix and VBeam Pro platforms are currently available in select EMEA markets and are expected to be comprehensively launched shortly, further strengthening Candela’s leadership in the energy-based device market. Unveiled at the IMCAS World Congress 2026, these launches underscore Candela’s continued commitment to delivering innovative, science-backed treatment solutions for high-demand patient needs. Candela leads the industry in clinical efficacy and safety, suppo
Merz Therapeutics Appoints Dan Staner as President, Region Europe30.1.2026 08:00:00 CET | Press release
Merz Therapeutics today announced the appointment of Dan Staner as President, Region Europe, effective February 1, 2026. In this role, Dan will oversee the company’s European business and drive regional growth. Dan will report directly to Merz Therapeutics Chief Executive Officer, Stefan König, and will join the Therapeutics Executive Team. His appointment reflects the company’s continued commitment to strengthening its leadership capabilities and accelerating its growth strategy across key European markets. “Dan brings a strong track record of building and scaling biopharmaceutical businesses across Europe,” said Stefan König, CEO of Merz Therapeutics. “His deep commercial, strategic, and regional leadership experience will be instrumental in advancing our growth ambitions, expanding patient access to our therapies, and further strengthening our presence in Europe. We are very pleased to welcome Dan to Merz Therapeutics.” Throughout his career, Dan has held senior leadership roles i
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
